Extended NICE drug-eluting stent consultation comes to an end:
This article was originally published in Clinica
Executive Summary
Next week sees the end of the extended consultation by the UK's National Institute for Health and Clinical Excellence (NICE) on NHS use of drug-eluting stents (DESs) to treat coronary artery disease. After allowing an extra month - to October 1 - for commenting on economic modelling data added to the consultation documentation on August 30 (two days after the original August 28 deadline - see Clinica No 1272, p 7), NICE's first appraisal committee meeting is now due to be held in November. Subject to any appeals process, the final guidance is scheduled for publication in March 2008.